| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/05/2008 | WO2008065637A1 Treatment of disease |
| 06/05/2008 | WO2008065636A2 Treatment of disease by modulating cf5 protein |
| 06/05/2008 | WO2008065503A1 (r) -5-methyl-4, 5-dihydro- pyrazole-1, 5-dicarboxylic acid 1- [ ( 4 -chlorophenyl) amide 5-{ [2-fluoro-4- (2-oxo-2h-pyridin-1-yl) -phenyl]amide) as a factor xa inhibitor |
| 06/05/2008 | WO2008065428A2 Steroid sulphatase inhibitors for treating hormone dependent cancer |
| 06/05/2008 | WO2008065409A2 Combination for use in the treatment of cancer, comprising tamoxifen or an aromatase inhibitor |
| 06/05/2008 | WO2008065193A1 Combination product containing n-desmethylsertraline, or a salt thereof, and an antineoplastic agent for the treatment of cancer |
| 06/05/2008 | WO2008065054A1 Tricyclic indoles and (4,5-dihydro) indoles |
| 06/05/2008 | WO2008065053A1 Multi-modal cancer therapy using viral hitch-hiking |
| 06/05/2008 | WO2008064866A1 Treatment for multiple myeloma |
| 06/05/2008 | WO2008064849A1 Crystalline forms of zoledronic acid |
| 06/05/2008 | WO2008064596A1 Pharmaceutical composition comprising p43 protein for the treatment of gastric adenocarcinoma |
| 06/05/2008 | WO2008064570A1 The use of granulin-epithelin precursor (gep) antibodies for detection and suppression of hepatocellular carcinoma (hcc) |
| 06/05/2008 | WO2008064558A1 Bromo-dihydroartemisinin and its preparation |
| 06/05/2008 | WO2008064540A1 Compositions comprising adeno-associated virus-mediated anti-angiogenic factor-hgfk1 and uses thereof |
| 06/05/2008 | WO2008064425A1 Glycoalkaloid and chemotherapeutic agent combinations and various uses thereof |
| 06/05/2008 | WO2008037257A3 Anti-cd38 plus corticosteroids plus a non-corticosteroid chemotherapeutic for treating tumors |
| 06/05/2008 | WO2008035228A3 2- substituted-1alpha, 25-dihydroxy-19,26,27-trinor vitamin d analogs and uses thereof |
| 06/05/2008 | WO2008034909A3 Second line treatment of metastatic hormone refractory prostate cancer using satraplatin |
| 06/05/2008 | WO2008024027A3 Use of 9-oxoacridine-10-acetic acid, its salts and esters for enhancing the efficacy of antiandrogenic treatment |
| 06/05/2008 | WO2008017473A3 Structure and use of 5' phosphate oligonucleotides |
| 06/05/2008 | WO2007128588A3 Glutadon |
| 06/05/2008 | WO2007118214A3 Antibody compositions and methods for treatment of neoplastic disease |
| 06/05/2008 | WO2007115805A3 Aurora kinase inhibitors |
| 06/05/2008 | WO2007106915A3 Antibodies to egfl7 and methods for their use |
| 06/05/2008 | WO2007059106A3 Administration of mntor inhibitor to treat patients with cancer |
| 06/05/2008 | US20080132963 Method and apparatus for treating tumors using low strength electric fields |
| 06/05/2008 | US20080132706 Compounds as PDE IV and TNF Inhibitors |
| 06/05/2008 | US20080132704 3-Substituted quinuclidines and their use |
| 06/05/2008 | US20080132678 Such as N-(4-morpholine)carbonyl-(O-benzyl)-L-tyrosine-L-leucine boronic acid for reducing rate of degradation of proteins; proteasome inhibitors |
| 06/05/2008 | US20080132575 specific dissolution profile; specific particle size distribution |
| 06/05/2008 | US20080132574 Leukotriene B4 receptor binding activity; treatment of skin disease such as psoriasis, eczema, skin cancer, keratosis, dyspigmentation or psilosis |
| 06/05/2008 | US20080132554 Crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
| 06/05/2008 | US20080132541 immunomodulatory compound is administered in combination with a therapy conventionally used to treat, prevent or manage cancer; potent inhibition of TNF- alpha but also marked inhibition of LPS |
| 06/05/2008 | US20080132528 Kinase inhibitors and methods for using the same |
| 06/05/2008 | US20080132525 isoforms DNMT1 and DNMT3b2; for example: 2-amino-4-(((2S,3S,4R,5R)-3,4-dihydroxy-5-(6-(phenethylamino)-9H-purin-9-yl)-tetrahydrofuran-2-yl)methylthio)butanoic acid |
| 06/05/2008 | US20080132504 2, 4-Pyrimidinediamines Useful In The Treatment Of Neoplastic Diseases, Inflammatory And Immune System Disorders |
| 06/05/2008 | US20080132503 Inhibitors of Histone Deacetylase |
| 06/05/2008 | US20080132502 Phosphatidylinositol (PI) 3-kinase (PI3K); N-[5-(5-Benzylamino-6-chloropyridin-3-yl)-4-methyl-1,3-thiazol-2-yl]acetamide, for example; anticancer agents, cardiovascular disorders, autoimmune disorders, rheumatic diseases |
| 06/05/2008 | US20080132497 Novel Heterocycles |
| 06/05/2008 | US20080132495 Pyrazole Compounds that Modulate the Activity of Cdk, Gsk and Aurora Kinases |
| 06/05/2008 | US20080132485 Amide substituted heterocylic compound; anticarcinogen; inducing apoptotic cell death, sensitizing cells to inducers of apoptosis |
| 06/05/2008 | US20080132484 Screening for a modulator of Polio Like Kinase, designing and identifying small molecule inhibitors using a homology model for PLK |
| 06/05/2008 | US20080132481 Use of 3-substituted amino-2-carboxy-substituted indoles or benzo(b)thiophenes or esters thereof that modulate T helper (Th) cells; treating allergy, asthma, rhinitis, dermatitis, B-cell lymphomas, tumors and diseases associated with bacterial, rhinovirus or respiratory syncytial virus (RSV) infections |
| 06/05/2008 | US20080132474 Breast cancer screening and treatment methods |
| 06/05/2008 | US20080132459 Inhibitors of Histone Deacetylase |
| 06/05/2008 | US20080132458 (8S,10S)-10-(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione |
| 06/05/2008 | US20080132453 amino acid sequence: One example is Nal-Tyr-cyclo(D-Cys-D-Trp-Lys-D-Cys)-Abu-Nal-NH2; lung cancer, glioma, anorexia, hypothyroidism; various D-amino acid-substituted and constrained amino acid-substituted cyclo somatostatin analogs that function as potent mu opioid receptor antagonists |
| 06/05/2008 | US20080132446 Uses of neuronal pannexins for therapy and diagnosis in mammals |
| 06/05/2008 | US20080132445 increasing milk production; inhibiting tumors; administering Galanin with prolactin; transgenic mammal |
| 06/05/2008 | US20080131976 Novel G protein coupled receptor protein, DNA its ligand |
| 06/05/2008 | US20080131889 Novel human genes and gene expression products: II |
| 06/05/2008 | US20080131871 Using vector comprisng nucleotide sequences coding cell binding elements to transform cells and identify lymphocyte response modulators |
| 06/05/2008 | US20080131565 Edible composition; partially defatted cocoa solids prepared by heating slaty and/or purple cocoa beans, winnowing the cocoa nibs from the cocoa shells; pressing the cocoa nibs to produce cocoa butter, recovering the cocoa butter and solids; adding the recovered, defatted cocoa solids |
| 06/05/2008 | US20080131526 Akt sensitization of cancer cells |
| 06/05/2008 | US20080131495 method for treating an individual who is afflicted with a cancer, such as non-small cell lung cancer or prostate cancer, by administering to that individual a MUC-1 based formulation. The formulation may be a MUC-1 based liposomal vaccine formulation. |
| 06/05/2008 | US20080131448 Using interleukin receptor as tool in treatment cell proliferative disorders; antitumor agents |
| 06/05/2008 | US20080131443 Method and composition for reconforming multi-epitopic antigens to intiate an immune response |
| 06/05/2008 | US20080131438 Antibodies to non-functional p2x7 receptor |
| 06/05/2008 | US20080131436 Polypeptide Compounds for Inhibiting Angiogenesis and Tumor Growth |
| 06/05/2008 | US20080131430 Therapeutic Administration Of The Scrambled Anti-Angiogenic Peptide C16Y |
| 06/05/2008 | US20080131423 Triggering receptors expressed on myeloid cells (TREMs) specific immunoglobulin for use in prevention and treatment of blood coagulation disorders |
| 06/05/2008 | US20080131407 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 06/05/2008 | US20080131403 Recombinant Adeno-Associated Virus Expressing human Antisense Gene Cyp2j2 and Its Preparation Methods |
| 06/05/2008 | US20080131401 Using starch mixture as carrier agent for localizing preferential probiotic organisms |
| 06/05/2008 | US20080131399 Using interferon alpha chimera to treat and prevent cell proliferative and viral diseases |
| 06/05/2008 | US20080131396 Using cytokine mixture as localizing tool in tissue target therapy of cell proliferative masses |
| 06/05/2008 | US20080131376 Carboranylporphyrins and uses thereof |
| 06/05/2008 | US20080131366 Administering folate receptor alpha inducer comprising steroid receptor agent optionally with one or more histone deacetylase inhibitors to treat or diagnose a patient having a solid tumor; increases levels of receptors on cancer cell plasma membranes and in serum, ascites and cerebrospinal fluid |
| 06/05/2008 | US20080131363 Rs7 antibodies |
| 06/05/2008 | DE102006056604A1 A peptide which correlates with the proteolytic activity of a tumor-suppressor protein, especially retinoblastoma protein or insulin-degrading enzyme, used for the diagnosis and prognosis of diseases, especially cancer |
| 06/05/2008 | CA2673483A1 Compositions of chk1 inhibitors |
| 06/05/2008 | CA2672327A1 Aza-indolyl compounds and methods of use |
| 06/05/2008 | CA2670790A1 Polypeptides comprising fas activation and nkg2d-ligand domains |
| 06/05/2008 | CA2670778A1 Use of indolyl-3-glyoxylic acid derivatives including indibulin, alone or in combination with further agents for treating cancer |
| 06/05/2008 | CA2670638A1 Organic compounds |
| 06/05/2008 | CA2670628A1 2-{[2-(substituted amino)ethyl]sulfonyl}ethyl n,n,n',n'-tetrakis(2 -chloroethyl)phosphorodiamidates |
| 06/05/2008 | CA2670595A1 (r)-5-methyl-4,5-dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chlorophenyl)amide 5-{[2-fluoro-4-(2-oxo-2h-pyridin-1-yl)-phenyl)amide) as a fact or xa inhibitor |
| 06/05/2008 | CA2670498A1 Combination of iap inhibitors and flt3 inhibitors |
| 06/05/2008 | CA2670445A1 Binding members for interleukin-6 |
| 06/05/2008 | CA2670105A1 Substituted dihydroimidazoles and their use in the treatment of tumors |
| 06/05/2008 | CA2669184A1 Method of diagnosing and treating glioma |
| 06/05/2008 | CA2668579A1 Cis-cyclohexyl substituted pyrimidinone derivatives |
| 06/05/2008 | CA2667846A1 Substituted pyrazoles, compositions containing these, method of production and use |
| 06/04/2008 | EP1927368A2 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 06/04/2008 | EP1927367A1 Novel pharmaceutical using anti-hla antibody |
| 06/04/2008 | EP1927352A2 Therapeutic methods and compositions involving isoflavones |
| 06/04/2008 | EP1926750A2 Biological materials and uses thereof |
| 06/04/2008 | EP1926737A1 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives |
| 06/04/2008 | EP1926734A1 Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators |
| 06/04/2008 | EP1926725A1 Alkoxy indolinone based protein kinase inhibitors |
| 06/04/2008 | EP1926724A1 Analogs of dehydrophenylahistins and their therapeutic use |
| 06/04/2008 | EP1926722A1 Substituted benzimidazoles as kinase inhibitors |
| 06/04/2008 | EP1926721A2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 06/04/2008 | EP1926495A2 Therapeutic use of outer shigella protein f (os pf) |
| 06/04/2008 | EP1493033B1 Use of sc6 for diagnosis and treatment of breast carcinoma |
| 06/04/2008 | EP1478339B1 Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same |
| 06/04/2008 | EP1463754B1 Cystine-knot fold protein |
| 06/04/2008 | EP1392688B1 Pyrazino[1',2':1,6]-pyrido[3,4-b] indole-1,4-dione derivatives |
| 06/04/2008 | EP1365781B1 Acrochordon alleviation |
| 06/04/2008 | EP1308168B1 Novel remedies for cancer |